Table of Contents
Government-insured patients may use this program if they self pay and process outside of their insurance
Using Metformin for weight loss, is not officially approved by health authorities as a weight loss drug, some healthcare providers may recommend the off-label use of Metformin for weight loss purposes
Not allowing the pen to reach room temperature before injection: Injecting cold medication directly from the refrigerator may cause discomfort
Some possible healthcare-related risks of obesity include: Type 2 diabetes Heart disease and heart attacks Arthritis Gallbladder and fatty liver disease High cholesterol and high blood pressure Circulation problems and increase risks for stroke Infertility Osteoarthritis, in particular, the knees Sleep apnea and other breathing problems Certain kinds of cancer endometrial, breast, and colon Strain on bones, joints, and muscles due to increased weight Mobility issues Metabolic syndrome Emotional issues kidney disease and many others Semaglutide May Also Decrease Cardiometabolic Risks in Obese Patients Some medical experts predict that if obesity cases continue to rise, research has shown over the past three decades in the U.S., up to 50% of the population may be diagnosed with obesity by the year 2030
Obesity and kidney disease: hidden consequences of the epidemic
